Scout, which is claimed to be the first medical device to use radar in human tissue, is a tool for localizing and directing the removal of non-palpable breast lesions.
Scout system features a reflector, which can be placed at the tumor site up to 30 days before a lumpectomy or surgical biopsy.
During the procedure, the surgeon will scan the breast using the Scout handpiece that emits infrared light and a micro-impulse radar signal to detect the location of the reflector.
Real-time audible and visual indicators help the surgeon to accurately locate the reflector and target tissue.
Cianna Medical president and CEO Jill Anderson said: “Extending the timeframe between tumor localization and surgical intervention has the potential to improve scheduling flexibility for patients, physicians and health systems, further supporting the use of radar as a desirable platform technology for tumor localization.
“Scout is a novel technology, requiring no radiation or invasive wires, that has demonstrated the potential to drive value by reducing costs and improving patient outcomes.”
According to the company, the standard preoperative technique for localizing non-palpable breast lesions is wire localization (WL).
The procedure involves the insertion of the wire into the breast by a radiologist to guide the surgeon to the target tissue.
Cianna Medical develops and markets medical technologies for breast cancer treatment.
